Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$181K Hold
501
0.09% 58
2026
Q1
$176K Hold
501
0.09% 56
2025
Q4
$164K Hold
501
0.07% 64
2025
Q3
$141K Sell
501
-100
-17% -$29K 0.07% 59
2025
Q2
$187K Hold
601
0.11% 50
2025
Q1
$187K Hold
601
0.11% 50
2024
Q4
$157K Buy
+601
New +$178K 0.08% 54

Other funds holding AMGN

Banque de Luxembourg's AMGN Position: Q2 2026 in Review

Banque de Luxembourg held its Amgen (AMGN) position steady in Q2 2026 at 501 shares worth $181K. The position accounts for 0.09% of the portfolio, ranked #58.

Banque de Luxembourg first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $187K in Q2 2025. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Banque de Luxembourg held 501 shares of Amgen worth $181K as of Q2 2026.
  • Banque de Luxembourg left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.09% of Banque de Luxembourg's portfolio in Q2 2026, its #58 holding.
  • Banque de Luxembourg first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • Banque de Luxembourg's Amgen position peaked at $187K in Q2 2025.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Banque de Luxembourg's 13F filing for Q2 2026, filed 9 Jul 2026.